InvestorsHub Logo
Followers 0
Posts 75440
Boards Moderated 6
Alias Born 05/24/2005

Re: None

Monday, 06/01/2015 7:50:27 AM

Monday, June 01, 2015 7:50:27 AM

Post# of 3632
Big News From Clovis presented Sunday morning at ASCO! TBIO will spike!
Stage 3 4 and 5 EGFR mutant lung cancer patients showing incredible progression free survival from Clovis breakthrough designated treatment Rociletinib. This is probably the biggest breakthrough news in oncology at ASCO. And all patients need liquid sample EGFR mutant detection to get treatment! What a huge break for TBIO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRPO News